Log In / Sign Up

SB 727

  • Wisconsin Senate Bill
  • 2023-2024 Regular Session
  • Introduced in Senate Nov 21, 2023
  • Senate
  • Assembly
  • Governor

Relating to: creating a medicinal psilocybin treatment fund and a pilot program to study the effects of medicinal psilocybin treatment on patients with post-traumatic stress syndrome at the University of Wisconsin-Madison and making an appropriation. (FE)

View Latest Bill Text
Sign In to Follow

Abstract

Bill Sponsors (6)

Jesse James

  • Republican
  • Senator
  • District 23
Primary

Dianne Hesselbein

  • Democratic
  • Senator
  • District 27
Primary

Melissa Agard

  • Democratic
  • Senator
  • District 16
Primary

Chris Larson

  • Democratic
  • Senator
  • District 7
Primary

Kelda Roys

  • Democratic
  • Senator
  • District 26
Primary

Mark Spreitzer

  • Democratic
  • Senator
  • District 15
Primary

Votes

No votes to display

Actions

Apr 15, 2024

Senate

Failed to pass pursuant to Senate Joint Resolution 1

Jan 04, 2024

Senate

Fiscal estimate received

Dec 15, 2023

Senate

Representative Madison added as a cosponsor

Nov 27, 2023

Senate

Representative Haywood added as a cosponsor

Nov 21, 2023

Senate

Introduced by Senators James, Hesselbein, Agard, Larson, Roys and Spreitzer; cosponsored by Representatives Gustafson, C. Anderson, J. Anderson, Bare, Brooks, Considine, Edming, Emerson, Jacobson, Joers, Murphy, Ohnstad, Ortiz-Velez, Ratcliff, Sapik, Shankland and Sinicki

Senate

Read first time and referred to Committee on Universities and Revenue

Bill Text

Bill Text Versions Format
Bill Text PDF HTML

Related Documents

Document Format
2023 Assembly Bill 753 HTML
Wisconsin Ethics Commission information HTML
SB727 ROCP for Committee on Universities and Revenue HTML
SB727: Fiscal Estimate From UWS

Sources

Data on Open States is updated periodically throughout the day from the official website of the Wisconsin State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.